News

Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer.

A protein in the immune system programmed to protect the body from fungal infections is also responsible for exacerbating the severity of certain autoimmune diseases.

A common drug used for rheumatoid arthritis – baricitinib – has shown promising results for patients with type 1 diabetes in a world-first trial, showing it could limit the progression of the disease within the first 100 days of diagnosis.

An under-the-skin implant that secretes insulin could provide an easier, long-term and less invasive way to treat type 1 diabetes.

A new study has demonstrated how bacteria use the viscosity of mucus to enhance their ability to self-organize and possibly drive infection.

Designing small molecule drugs that target the androgen receptor is a major challenge, but the way it forms condensates could reveal a new way of targeting the receptor.

Aspirin is inexpensive and readily available in almost every country. According to a meta-analysis, taking a daily low dose (75 or 81 mg/day) of aspirin was associated with a 20% reduction in deaths from cancer and in deaths from all causes.

Technology Networks caught up with the researchers behind an eight-week clinical trial testing the effects of Bikram yoga on depressive symptoms.

Combining a pair of experimental drugs may help treat malignant peripheral nerve sheath tumors with fewer harmful side effects, according to preliminary animal studies.

A class of small molecules has been shown to help mice regain brain function after a stroke, opening doors to new stroke recovery therapies.